-
公开(公告)号:US20090319052A1
公开(公告)日:2009-12-24
申请号:US12309789
申请日:2007-07-23
CPC分类号: A61L27/56 , A61K6/027 , A61K8/25 , A61L27/10 , A61L27/425 , A61Q11/00 , C03C1/006 , C03C3/04 , C03C4/0007 , C04B35/057 , C04B35/14 , C04B35/447 , C04B38/0032 , C04B38/0045 , C04B2111/00836 , C04B38/0054
摘要: A calcium oxide-silica composite biomaterial either in amorphous state or crystalline state having an average pore size, as determined by the BET method, in the range of from 0.8 to 4 nm, wherein the calcium oxide-silica content of the biomaterial is at least 80 wt %, the balance being optionally one or more other materials and wherein the molar ratio of calcium oxide to silica is at least 0.1.
摘要翻译: 一种氧化钙 - 二氧化硅复合生物材料,其无定形状态或结晶态具有通过BET法测定的平均孔径,范围为0.8至4nm,其中生物材料的氧化钙 - 二氧化硅含量至少为 80重量%,余量可选地为一种或多种其它材料,并且其中氧化钙与二氧化硅的摩尔比为至少0.1。